Ferro-Carbon Particles

Preparation and Clinical Applications
  • Anatoly A. Kuznetsov
  • Avetik R. Harutyunyan
  • Edward K. Dobrinsky
  • Victor I. Filippov
  • Andrei G. Malenkov
  • Anatoly F. Vanin
  • Oleg A. Kuznetsov


A variety of magnetic adsorbents for different biomedical applications have been developed. The adsorbents are fine disperse particles, consisting of a ferromagnetic core made of iron or its oxides, and attached to a carbon structure or coated with carbon. The size of the particles is 0.01 to 1 µm. The carbon phase is porous, has a considerable specific surface and is a good adsorbent. It can be manufactured with selective sorption properties. The ferromagnetic core allows the use of a magnetic field to guide and move the particles and regulate their agglomeration behavior. The particles were produced by three different methods, and their sorption properties, shape, size distribution, magnetic and biological properties were studied. The particles were successfully used in several biomedical applications, including magnetic localization of anti-cancer drugs in the tumor zone. Magnetic targeting allows to create a hundred times higher concentrations of anti-cancer antibiotics in the tumor compared with other organs, which is maintained for 8 to 10 days after a single injection. Animal and pre-clinical trials have been completed and permission for clinical trials on cancer patients with high grade disease was obtained. Since 1990, more than a hundred patients with different types of tumors have been treated in several Russian clinics. Many patients had either full recovery or their condition was considerably improved.


Iron Particle Weak Magnetic Field Iron Carbonyl Adsorbent Particle Magnetic Localization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Chang Zhie C, Ming Rong T et al (1986). Removal of unconjugated bilirubin by macro reticular resin in hemoperfusion. J. Artif. Organs 9, 320–326.Google Scholar
  2. 2.
    Chikov VM, Kuznetsov AA, Schütt W (1991). Analytical cell magnetophoresis. In Physical characterization of biological cells. Verlag Gesundheit GmbH Berlin, 381–389.Google Scholar
  3. 3.
    Demirel Kibarer (1994). Interesting features of an activated carbon supported urease system. J. Artif Organs 18, 127–135.Google Scholar
  4. 4.
    Dobrinsky EK et al (1985). USSR patent # 221368.Google Scholar
  5. 5.
    Kato T, Nemoto R, et al (1980). Sustained release property of microencapsulated mitomycin C with ethyl cellulose infused into the renal artery of a dog. J. Cancer 48, 14–21.CrossRefGoogle Scholar
  6. 6.
    Kutushov MV, Kuznetsov AA, Filippov VI, Kuznetsov OA (1997). New method of biological fluid detoxification based on magnetic adsorbents. This book.Google Scholar
  7. 7.
    Kuznetsov AA, Chikov VM, Shapiro AM, Winoto-Morbach S, Muller-Rucholtz W (1993). Single cell magnetophoresis and its diagnostic value. J. Magnetism & Magnetic Materials 122, 367–370.ADSCrossRefGoogle Scholar
  8. 8.
    Kuznetsov AA, Holodov LE, Volkonsky VA, Kolesnik NF, Priluckii OV, Filippov VI, Lipakhin VK, Belousov YuB, Sedov AN (1989). Magnetically guided carrier with physiologically active substance and method of its production. USSR patent #1722256, claim SU 4767768. Europatent #90917517.6 (1990). US patent application #730837.Google Scholar
  9. 9.
    Kuznetsov AA, Holodov LE, Kolesnik NF, Priluzki OV, Volkonski VA (1992). Magnetically controlled metal-carbon carrier of anti-tumor drugs and method of its application. Proc. 6th Int. Conf. Magnetic Fluids, Paris, 474–475Google Scholar
  10. 10.
    Kuznetsov AA, Kuznetsov OA, Harutunyan AR (1995). Magnetic colloids and suspensions based on metal-carbon particles. Abst. 7th Int. Conf. Magnetic Fluids, Bhavnagar, India.Google Scholar
  11. 11.
    Kuznetsov AA, Makhmudov SY, Filippov VI, Kuznetsov OA (1995). Protection of implants using magnetically guided transport of pharmacological preparations. Abst. 7th Int. Conf. Magnetic Fluids, Bhavnagar, India.Google Scholar
  12. 12.
    Kuznetsov OA, Komissarov GG (1993). Method of magnetic levitational suspension and its application for registration of oxygen evolving by a single photosynthetic object. Biofizika 38, 554.Google Scholar
  13. 13.
    Landau LD, Lifshitz EM (1973). The field theory. Vol. 2, Moscow, Nauka, 128–136.Google Scholar
  14. 14.
    Makhmudov SYa, Kuznetsov AA, Filippov VI (1997). Application of magnetically guided transport of medications for pathological conditions prophylactics and protection of implants. This book.Google Scholar
  15. 15.
    Nakamura T (1971). Magnetomedicine characteristics of fine ferromagnetic particles. J. Appl. Phys. 42, 1320–1324.ADSCrossRefGoogle Scholar
  16. 16.
    Senyei A, Reich K, Conezy C, Widder K (1981). In vivo kinetics of magnetically targeted low-dose doxorubicin. J. Pharm. Science 70, 383–391.Google Scholar
  17. 17.
    Sivukhin DV (1983). General course of physics. Vol. 3 Electricity. Moscow, Nauka, 9–459.Google Scholar
  18. 18.
    Vladimirsky MA, Kuznetsov AA, Filippov VI (1993). A magnetic concentration method using hydrosol of ferric particles for diagnosing tuberculosis. J. Magnetism & Magnetic Materials 122, 371–373.ADSCrossRefGoogle Scholar
  19. 19.
    Vladimirsky MA, Filippov VI, Kuznetsov AA, Polozov Al, Dobrinsky EK (1997). Ferromagnetic and immunomagnetic concentration of mycobacteria for tuberculosis diagnostics. This book.Google Scholar
  20. 20.
    Widder K, Senyei A (1983). Magnetic microspheres: a vehicle for selective targeting of drugs. J. Pharm. Therapy 20, 377–396.CrossRefGoogle Scholar
  21. 21.
    Strumban EE, Dobrinsky EK, Kuznetsov AA, Harrutyunyan AR (1977). Method and apparatus for making carbon-encapsulated ultrafine metal particles. US Patent 5, 593, 740.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Anatoly A. Kuznetsov
    • 1
  • Avetik R. Harutyunyan
    • 2
  • Edward K. Dobrinsky
    • 2
  • Victor I. Filippov
    • 2
  • Andrei G. Malenkov
    • 2
  • Anatoly F. Vanin
    • 2
  • Oleg A. Kuznetsov
    • 2
  1. 1.Synmatix CorporationSouthfieldUSA
  2. 2.Institute of Biochemical PhysicsRussian Academy of SciencesMoscowRussia

Personalised recommendations